MariMed Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.6M | $-3.8M | $-4.6M | $-2.9M | $-1.4M | $-5.5M | $-8.5M | $-1.0M |
| Depreciation & Amortization | $2.3M | $2.2M | $2.1M | $2.1M | $2.1M | $1.8M | $2.2M | $1.8M |
| Depreciation | $2.3M | $2.2M | $2.1M | $2.1M | $2.1M | $1.8M | $2.2M | $1.8M |
| Amortization | $717.0K | $810.0K | $809.0K | $674.0K | $969.0K | $949.0K | $883.0K | $882.0K |
| Stock-Based Compensation | $350.0K | $325.0K | $382.0K | $382.0K | $549.0K | $547.0K | $278.0K | $280.0K |
| Net Cash from Operating Activities | $2.2M | $949.0K | $3.4M | $2.7M | $297.0K | $1.3M | $-413.0K | $803.0K |
| Investing Activities | ||||||||
| Capital Expenditures | $298.0K | $373.0K | $33.0K | $559.0K | $309.0K | $266.0K | $1.1M | $2.6M |
| Business Acquisitions | $0 | $0 | $0 | $0 | $0 | $-231.0K | $0 | $0 |
| Net Cash from Investing Activities | $-507.0K | $-753.0K | $-197.0K | $-514.0K | $-554.0K | $-115.0K | $-1.2M | $-2.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-1.2M | $-1.1M | $-944.0K | $-1.7M | $-806.0K | $-1.3M | $-893.0K | $917.0K |
| Net Change in Cash | $500.0K | $-947.0K | $2.3M | $458.0K | $-1.1M | $-81.0K | $-2.5M | $-404.0K |
| Free Cash Flow | $1.9M | $576.0K | $3.4M | $2.1M | $-12.0K | $1.0M | $-1.5M | $-1.8M |